Preterm InfantSenSyNoPPNCT05399914
Feasibility and Reliability of Synchronized Non-invasive Intermittent Positive Pressure Ventilation in Preterm Infants After Birth
An observational study of Preterm Infant and Delivery Room, run by University Hospital Tuebingen at 1 site in Germany.
Trial summary
The aim of this prospective observational study (pilot study) is to test if synchronized noninvasive positive pressure ventilation (S-NIPPV) is feasible and works appropriately during transition from intrauterine to extrauterine life in very preterm infants in the delivery room. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Preterm Infant, Delivery Room, Respiratory Support
- What is being tested?
- S-NIPPV
- How many people
- 10 participants
- Where
- 1 siteGermany
- Study dates
- 22 Apr 2022to 11 Oct 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Child, Adult, Older adult
Study population: Preterm infants born at University Hospital in Tübingen.
Who may be able to join
- Preterm infants with a gestational age (GA) between 26 ≥ and < 32 weeks
Who cannot join
- Major congenital malformations
- Refused parental consent (prenatal parental consent is necessary)
Trial locations and contacts
1 site in 1 country.
Germany1 site
University Hospital Tuebingen
Tübingen, Baden-Wurttemberg, 72076
About this study
The aim of this prospective observational study (pilot study) is to test if synchronized noninvasive positive pressure ventilation (S-NIPPV) is feasible and works appropriately during transition from intrauterine to extrauterine life in very preterm infants in the delivery room.
Read the detailed description
The study period will be the first 10 minutes after birth.
All patients will be non-invasively ventilated using an EVE NEO ventilator (CE 0482, Fritz Stephan GmbH, Gackenbach, Germany). A facemask will be used throughout the study period. Synchronization will be achieved using graseby capsule (Stephan, Vio Healthcare), which will be secured at the abdominal wall on the midaxillary line below the ribs. For the detection of spontaneous breaths respiratory induction plethysmography (RIP) is used. For this purpose, an extra small plethysmography belt (Sleepsense, Elgin, USA) is placed around the abdomen. The data of the plethysmography belts are processed and stored with the NewLifebox-XL (Advanced Life Diagnostics UG, Weener, Germany) and merged with the data from the ventilator for later evaluation.
Infants according to the clinician's assessment only needing CPAP will receive S-NIPPV with very low PIP levels. This enables to have enough ventilator breaths applied for analysis to obtain sufficient data about the synchronization rate of S-NIPPV in the delivery room and meanwhile consider the infant's safety by not applying high pressures where it might not be needed. The ventilator support settings will be PIP 10, PEEP 6 in the noninvasive pressure controlled assist control ventilation (nPC-ACV+) mode. In this mode every spontaneous breath is supported by a ventilator breath (if the triggering level is exceeded). The triggering level will be set at 0,5 to avoid autotriggering and unsupported breaths. The inspiratory time will be set at max. 0,3 sec. The backup ventilation rate is set at 60 per minute.The EVE NEO ventilator has in the nPC-ACV+ mode an option where the ventilator breaths are interrupted/stopped as soon as the graseby capsule detects a start of spontaneous expiration.
If the infant according to the clinician's assessment needs S-NIPPV (e.g. the infant is apnoeic, and/or heart rate is below 100 bpm), the pressure of S-NIPPV will be augmented to target PIP 20, PEEP 6 (unless clinical concerns require an adjustment). The respiratory support can be deescalated to PIP 10 once the clinician deems the higher pressure no longer necessary.
The following demographical characteristics will be collected from the patient charts (pseudonymized): gender, gestational age, birth weight, antenatal steroids, mode of delivery, reason for prematurity (prolong premature rupture of membrane, infection, pathologic CTG, pathological doppler, gestosis), time of cord clamping, umbilical cord pH, FiO2 requirement, APGAR.
The following interventions within the first 10 minutes after birth including the time will be noted: tactile stimulation, placement of an intravenous line, non-invasive surfactant administration, intubation, chest compression, administration of volume, catecholamine, blood or other medication.
- Conditions
- Preterm Infant, Delivery Room, Respiratory Support, Synchronized Noninvasive Positive Pressure Ventilation (SNIPPV)
- Being tested
- S-NIPPV
- Medical subject headings
- Premature Birth
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
S-NIPPVOther
Synchronized noninvasive positive pressure ventilation during the first 10 minutes after birth.
| Study group | Role | What they receive |
|---|---|---|
| Preterm infants with a gestational age (GA) between 26 ≥ and < 32 weeks | Not described Receives: Other: S-NIPPV |
What is being measured
The primary outcome is the main question the study is designed to answer.
Synchronisation rate
Synchronisation rate (sensitivity/true positive rate) of S-NIPPV in the delivery room meaning the proportion of graseby triggered synchronized ventilator breaths with corresponding RIP signal related to all spontaneous breaths detected by RIP.
Measured: First 10 minutes after birth
Secondary outcomes (21)
False negative rate
Proportion of non-synchronized ventilator breaths with corresponding RIP signal. This will be related to all spontaneous breaths detected by RIP.
Measured: First 10 minutes after birth
False positive rate
Proportion of graseby triggered ventilator breaths without corresponding RIP signal. This will be related to all ventilator breaths without a corresponding RIP signal (i.e. movement artefacts).
Measured: First 10 minutes after birth
Proportion of artifacts
Proportion of graseby triggered ventilator breaths without corresponding RIP signal. This will be related to all ventilator breaths.
Measured: First 10 minutes after birth
Specificity (true negative rate)
Proportion of ventilator breaths without corresponding RIP signal and with no graseby signal (i.e. during an apnoea). This will be related to all ventilator breaths without a corresponding RIP signal.
Measured: First 10 minutes after birth
Proportion of back up breaths
Proportion of ventilator breaths without corresponding RIP signal and with no graseby signal. This will be related to all ventilator breaths.
Measured: First 10 minutes after birth
Proportion of time of synchronised breaths, non-synchronized breaths, periods of apnoea and periods of movement artefacts occure within the first ten minutes of respiratory support.
Measured: First 10 minutes after birth
Time until the graseby capsule is attached to the infant's abdomen and the proportion of infants in whom the graseby capsule is attached within the first two minutes after birth.
Measured: First 10 minutes after birth
Proportion of time non invasive ventilator breaths will be applied.
Measured: First 10 minutes after birth
Peak inspiratory pressure (PIP)
Measured: First 10 minutes after birth
Positive end expiatory pressure (PEEP)
Measured: First 10 minutes after birth
Mean airway pressure (MAP)
Measured: First 10 minutes after birth
Td (time delay) graseby
Time between the initial increase of the abdominal RIP curve and the initial increase of the graseby curve.
Measured: First 10 minutes after birth
Td (time delay) ventilator
Time between the initial increase of the graseby curve and the beginning of the pressure curve.
Measured: First 10 minutes after birth
Ti ventilator
Inspiratory time of a ventilator breath
Measured: First 10 minutes after birth
Ti RIP
Inspiratory time of a spontaneous breath
Measured: First 10 minutes after birth
Ti excess
Calculated: ((Ti ventilator - Ti RIP)/Ti RIP)) x 100
Measured: First 10 minutes after birth
Swing RIP
Amplitude of the RIP curve calculated by subtracting the baseline RIP from the peak RIP curve, which is a surrogate parameter for the patient's respiratory effort.
Measured: First 10 minutes after birth
Number of tactile stimulations and other interventions on the patient
Number of tactile stimulations and other interventions on the patient (e.g. placement of intravenous line, non-invasive administration of surfactant, intubation, chest compression) are documented by video analysis.
Measured: First 10 minutes after birth
Heart rate
Measured: First 10 minutes after birth
Oxygen saturation
Measured: First 10 minutes after birth
Fraction of inspired oxygen
Measured: First 10 minutes after birth
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Jun 2022
- Study start22 Apr 2022
- Primary completion11 Oct 2023
- Study completion11 Oct 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Preterm InfantStudies of the same condition, open and under way.
- More trials run by University Hospital TuebingenThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 10 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital Tuebingen
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05399914
- Sponsor's protocol ID
- 310/2021BO1
- Acronym
- SenSyNoPP
- Status last verified
- Apr 2022
- First submitted
- 20 Apr 2022
- Last updated
- 23 Sep 2024
- Results posted
- No
- Individual data sharing
- Undecided
Publications
Warth PP, Ruegger CM, Gaertner VD, Braun W, Molnar K, Brozek J, Poets CF, Springer L. Synchronised Non-Invasive Intermittent Positive Pressure Ventilation in Very Preterm Infants After Birth: A Feasibility Study. Acta Paediatr. 2025 Dec;114(12):3159-3165. doi: 10.1111/apa.70220. Epub 2025 Jul 16.
PubMed 40665887
Study at a glance
From the registry record, last updated by the sponsor on 23 Sep 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Feasibility and Reliability of Synchronized Non-invasive Intermittent Positive Pressure Ventilation in Preterm Infants After Birth
- ClinicalTrials.gov ID
- NCT05399914
- Acronym / sponsor ID
- SenSyNoPP / 310/2021BO1
- Conditions
- Preterm Infant, Delivery Room, Respiratory Support, Synchronized Noninvasive Positive Pressure Ventilation (SNIPPV)
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 10 participants (actual)
- Lead sponsor
- University Hospital TuebingenUniversity, hospital or other
- Study start
- 22 Apr 2022 (actual)
- Primary completion
- 11 Oct 2023 (actual)
- Study completion
- 11 Oct 2023 (actual)
- First posted
- 1 Jun 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this prospective observational study (pilot study) is to test if synchronized noninvasive positive pressure ventilation (S-NIPPV) is feasible and works appropriately during transition from intrauterine to extrauterine life in very preterm infants in the delivery room.
Detailed description
The study period will be the first 10 minutes after birth.
All patients will be non-invasively ventilated using an EVE NEO ventilator (CE 0482, Fritz Stephan GmbH, Gackenbach, Germany). A facemask will be used throughout the study period. Synchronization will be achieved using graseby capsule (Stephan, Vio Healthcare), which will be secured at the abdominal wall on the midaxillary line below the ribs. For the detection of spontaneous breaths respiratory induction plethysmography (RIP) is used. For this purpose, an extra small plethysmography belt (Sleepsense, Elgin, USA) is placed around the abdomen. The data of the plethysmography belts are processed and stored with the NewLifebox-XL (Advanced Life Diagnostics UG, Weener, Germany) and merged with the data from the ventilator for later evaluation.
Infants according to the clinician's assessment only needing CPAP will receive S-NIPPV with very low PIP levels. This enables to have enough ventilator breaths applied for analysis to obtain sufficient data about the synchronization rate of S-NIPPV in the delivery room and meanwhile consider the infant's safety by not applying high pressures where it might not be needed. The ventilator support settings will be PIP 10, PEEP 6 in the noninvasive pressure controlled assist control ventilation (nPC-ACV+) mode. In this mode every spontaneous breath is supported by a ventilator breath (if the triggering level is exceeded). The triggering level will be set at 0,5 to avoid autotriggering and unsupported breaths. The inspiratory time will be set at max. 0,3 sec. The backup ventilation rate is set at 60 per minute.The EVE NEO ventilator has in the nPC-ACV+ mode an option where the ventilator breaths are interrupted/stopped as soon as the graseby capsule detects a start of spontaneous expiration.
If the infant according to the clinician's assessment needs S-NIPPV (e.g. the infant is apnoeic, and/or heart rate is below 100 bpm), the pressure of S-NIPPV will be augmented to target PIP 20, PEEP 6 (unless clinical concerns require an adjustment). The respiratory support can be deescalated to PIP 10 once the clinician deems the higher pressure no longer necessary.
The following demographical characteristics will be collected from the patient charts (pseudonymized): gender, gestational age, birth weight, antenatal steroids, mode of delivery, reason for prematurity (prolong premature rupture of membrane, infection, pathologic CTG, pathological doppler, gestosis), time of cord clamping, umbilical cord pH, FiO2 requirement, APGAR.
The following interventions within the first 10 minutes after birth including the time will be noted: tactile stimulation, placement of an intravenous line, non-invasive surfactant administration, intubation, chest compression, administration of volume, catecholamine, blood or other medication.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Preterm infants with a gestational age (GA) between 26 ≥ and < 32 weeks | – | Other: S-NIPPV |
Who may qualify
- Sex
- All
- Age groups
- Child, Adult, Older adult
- Study population
- Preterm infants born at University Hospital in Tübingen.
Key inclusion criteria (1 listed)
- Preterm infants with a gestational age (GA) between 26 ≥ and < 32 weeks
Key exclusion criteria (2 listed)
- Major congenital malformations
- Refused parental consent (prenatal parental consent is necessary)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| S-NIPPVSynchronized noninvasive positive pressure ventilation during the first 10 minutes after birth. | Other | Preterm infants with a gestational age (GA) between 26 ≥ and < 32 weeks |
Primary outcome
Synchronisation rate
Time frame: First 10 minutes after birth
Synchronisation rate (sensitivity/true positive rate) of S-NIPPV in the delivery room meaning the proportion of graseby triggered synchronized ventilator breaths with corresponding RIP signal related to all spontaneous breaths detected by RIP.
21 secondary outcomes
False negative rate
Time frame: First 10 minutes after birth
False positive rate
Time frame: First 10 minutes after birth
Proportion of artifacts
Time frame: First 10 minutes after birth
Specificity (true negative rate)
Time frame: First 10 minutes after birth
Proportion of back up breaths
Time frame: First 10 minutes after birth
Proportion of time of synchronised breaths, non-synchronized breaths, periods of apnoea and periods of movement artefacts occure within the first ten minutes of respiratory support.
Time frame: First 10 minutes after birth
Time until the graseby capsule is attached to the infant's abdomen and the proportion of infants in whom the graseby capsule is attached within the first two minutes after birth.
Time frame: First 10 minutes after birth
Proportion of time non invasive ventilator breaths will be applied.
Time frame: First 10 minutes after birth
Peak inspiratory pressure (PIP)
Time frame: First 10 minutes after birth
Positive end expiatory pressure (PEEP)
Time frame: First 10 minutes after birth
Mean airway pressure (MAP)
Time frame: First 10 minutes after birth
Td (time delay) graseby
Time frame: First 10 minutes after birth
Td (time delay) ventilator
Time frame: First 10 minutes after birth
Ti ventilator
Time frame: First 10 minutes after birth
Ti RIP
Time frame: First 10 minutes after birth
Ti excess
Time frame: First 10 minutes after birth
Swing RIP
Time frame: First 10 minutes after birth
Number of tactile stimulations and other interventions on the patient
Time frame: First 10 minutes after birth
Heart rate
Time frame: First 10 minutes after birth
Oxygen saturation
Time frame: First 10 minutes after birth
Fraction of inspired oxygen
Time frame: First 10 minutes after birth
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Sep 2024.
- Derived from this study: PubMed 40665887Warth PP, Ruegger CM, Gaertner VD, Braun W, Molnar K, Brozek J, Poets CF, Springer L. Synchronised Non-Invasive Intermittent Positive Pressure Ventilation in Very Preterm Infants After Birth: A Feasibility Study. Acta Paediatr. 2025 Dec;114(12):3159-3165. doi: 10.1111/apa.70220. Epub 2025 Jul 16.
- Individual participant dataSharing planned: Undecided
Related trials for Preterm Infant
Not yet recruiting
nCPAP-NAVA-Backup Versus Standard nCPAP for Severe Apnea in Preterm Infants ≤28 Weeks
Apnea of Prematurity
Recruiting
Study of the Influence of Intraperitoneal Insufflation of CO2 by Laparoscopy on the Short-term Evolution of Premature Infants With Ulcerative Necrotizing Enterocolitis
Preterm Birth, Enterocolitis, Necrotizing
Recruiting
Comparing Surfactant Administration Through Supraglottic Airway and Thin Catheter for Preterm Infants
Surfactant, Respiratory Distress Syndrome (Neonatal)
Recruiting
Optimization of Saturation Targets And Resuscitation Trial (OptiSTART)
Premature Infants, Bronchopulmonary Dysplasia
RecruitingObservational study
Growing Little PEAPODS Study
Premature Birth, Premature Infant
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Preterm Infant and Delivery Room, run by University Hospital Tuebingen at 1 site in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Synchronisation rate (time frame: First 10 minutes after birth). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05399914, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2024.